Gene: FLAD1
Official Full Name: flavin adenine dinucleotide synthetase 1provided by HGNC
Gene Summary: This gene encodes the enzyme that catalyzes adenylation of flavin mononucleotide (FMN) to form flavin adenine dinucleotide (FAD) coenzyme. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04105 | FLAD1 Knockout cell line (HeLa) | Human | FLAD1 | 1:3~1:6 | Negative | Online Inquiry |
KO04106 | FLAD1 Knockout cell line (HCT 116) | Human | FLAD1 | 1:2~1:4 | Negative | Online Inquiry |
KO04107 | FLAD1 Knockout cell line (HEK293) | Human | FLAD1 | 1:3~1:6 | Negative | Online Inquiry |
KO04108 | FLAD1 Knockout cell line (A549) | Human | FLAD1 | 1:3~1:4 | Negative | Online Inquiry |
FLAD1 Gene Knockout Cell Lines are genetically engineered cell lines in which the FLAD1 gene has been selectively disrupted. FLAD1 (FAD-dependent L-α-hydroxy acid dehydrogenase) plays a crucial role in cellular metabolism, particularly in the context of fatty acid β-oxidation and the production of coenzymes that facilitate several biochemical pathways. By creating knockout variants, researchers can effectively study gene function, elucidate metabolic pathways, and investigate the physiological roles of FLAD1 in various biological contexts, including energy metabolism, cell signaling, and disease states.
The key mechanism underlying the utility of FLAD1 Gene Knockout Cell Lines lies in their ability to provide a controlled environment for the exploration of FLAD1's contributions to metabolic processes. By comparing these knockout cells with wild-type counterparts, scientists can delineate the consequences of FLAD1 deficiency, enabling them to understand how perturbations in this gene contribute to metabolic disorders, cancer, and other conditions.
In scientific research and clinical settings, these cell lines serve as powerful tools for drug discovery, biomarker identification, and the development of targeted therapies. Their application extends to understanding the mechanistic basis of diseases where FLAD1 is implicated, thereby facilitating the advancement of innovative therapies.
The advantages of FLAD1 Gene Knockout Cell Lines over traditional models are manifold. They offer precise genetic modifications that reduce variability and enhance reproducibility in experimental results. Additionally, these knockout lines can be easily incorporated into high-throughput screening platforms, enhancing the efficiency of research programs.
For researchers and clinicians, possessing access to FLAD1 Gene Knockout Cell Lines represents a significant opportunity to drive forward their understanding of metabolic regulation and disease pathology. By leveraging this product, users can advance their research capabilities, ultimately translating discoveries into improved health outcomes.
Our company specializes in providing high-quality, genetically engineered cell lines tailored to the specific needs of the scientific community. With a commitment to innovation and excellence, we aim to support your research endeavors with reliable and effective biological tools.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.